Cambridge University Hospitals NHS Foundation Trust

Cambridge, England CB2 0QQ

0 studies enrolling now · 6 studies all time

What they study most

Cirrhosis, Liver, Crohn's Disease, Macular Edema, NASH, NASH - Nonalcoholic Steatohepatitis, Non-small Cell Lung Cancer, Primary Biliary Cholangitis, Ulcerative Colitis, Uveitis

Studies at this site

• A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) — Running, not enrolling
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial — Completed
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis — Completed
• Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) — Completed
• Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer — Stopped early